16.46

0.30% +0.05

Lenz Therapeutics Inc (LENZ)

Overview News Price History Discussions Forecast

Lenz Therapeutics Inc stock is currently priced at $16.46, with a 24-hour trading volume of 202.11K. It has seen a +0.30% increased in the last 24 hours and a +0.00% rose in the past month. The chart indicates a potential bullish trend, as the stock is above the $16.21 pivot point. If it approaches the $16.82 resistance level, significant changes may occur.

Previous Close:

$16.41

Open:

$16.78

24h Volume:

202.11K

Market Cap:

$420.28M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

+4.71%

1M Performance:

+0.00%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1D Range:

$16.12

$16.79

52W Range:

$15.05

$22.04

Lenz Therapeutics Inc Stock (LENZ) Company Profile

Name

Lenz Therapeutics Inc

Sector

Healthcare (1213)

Industry

Biotechnology (699)

Phone

(650) 484-0886

Address

611 GATEWAY BLVD, SUITE 120, SOUTH SAN FRANCISCO

Employee

Twitter

Next Earnings Date

Latest SEC Filings

LENZ's Discussions on Twitter

Lenz Therapeutics Inc Stock (LENZ) Latest News

LENZ Therapeutics to Report First Quarter Financial Results and Business Update on May 8, 2024

GlobeNewswire Inc.

Blindness-Focused LENZ Therapeutics' Investigational Eye Drop Ready To Revolutionize Presbyopia Landscape, Analyst Says

Benzinga

Lenz Therapeutics Inc Stock (LENZ) Financials Data

There is no financial data for Lenz Therapeutics Inc (LENZ). Check out other stocks for more information.

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.